Want to see CON full AI Analyst Report?
CON Stock Chart & Stats
$34.78
$0.08(0.25%)
At close: 4:00 PM EDT
$34.78
$0.08(0.25%)
Day’s Range― - ―
52-Week Range$18.55 - $36.71
Previous CloseN/A
Volume1.25M
Average Volume (3M)860.95K
Market Cap
$4.46B
Enterprise Value$5.82K
Total Cash (Recent Filing)$158.04M
Total Debt (Recent Filing)$2.14B
Price to Earnings (P/E)22.6
Beta0.64
Next Earnings
Oct 29, 2026EPS Estimate
0.44Next Dividend Ex-DateN/A
Dividend Yield0.71%
Share Statistics
EPS (TTM)1.55
Shares Outstanding127,517,740
10 Day Avg. Volume1,269,833
30 Day Avg. Volume860,950
Financial Highlights & Ratios
PEG Ratio2.05
Price to Book (P/B)6.34
Price to Sales (P/S)1.15
P/FCF Ratio12.65
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$41.00Price Target Upside17.88% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)1.65
Revenue Forecast (FY)$2.35B
Bulls Say, Bears Say
Bulls Say
Revenue And Visit GrowthRevenue growth across total and core operations, combined with higher revenue per visit, indicates broad demand and pricing execution. This supports operating leverage and reinvestment, while the core increase reduces reliance on the acquired Pivot contribution over coming quarters.
Improving Cash GenerationOperating and free cash flow rose sharply year over year, while net leverage improved ahead of schedule. Stronger internal cash generation can fund expansion and debt reduction, giving the business greater flexibility even as it continues investing in clinics and services.
Leadership ContinuityThe planned CFO-to-CEO transition promotes executives already involved in strategy, capital structure and investor relations. That continuity may reduce disruption in capital allocation and execution as Concentra expands its occupational and workforce health platform.
Bears Say
Elevated LeverageHigh debt and a materially smaller equity cushion leave Concentra more sensitive to operating weakness, refinancing requirements and interest costs. Although recent leverage improved, the company still targets further reduction, so financial flexibility remains constrained.
Seasonal Margin VariabilityRecent margin expansion may not fully represent the earnings profile across the year because the strongest seasonal quarters are concentrated in Q2 and Q3. Lower margins later in the cycle could moderate cash conversion and make profitability less consistent.
Slow De Novo RampThe planned clinic openings expand Concentra’s footprint but are unlikely to provide meaningful near-term revenue or cash flow. Slow initial ramps defer returns on invested capital and place greater reliance on existing centers and acquisitions to deliver growth.
Concentra Group Holdings Parent, Inc. News
CON FAQ
What was Concentra Group Holdings Parent, Inc.’s price range in the past 12 months?
Concentra Group Holdings Parent, Inc. lowest stock price was $18.55 and its highest was $36.71 in the past 12 months.
What is Concentra Group Holdings Parent, Inc.’s market cap?
Concentra Group Holdings Parent, Inc.’s market cap is $4.46B.
When is Concentra Group Holdings Parent, Inc.’s upcoming earnings report date?
Concentra Group Holdings Parent, Inc.’s upcoming earnings report date is Oct 29, 2026 which is in 32 days.
How were Concentra Group Holdings Parent, Inc.’s earnings last quarter?
Concentra Group Holdings Parent, Inc. released its earnings results on Aug 06, 2026. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.422 by $0.098.
Is Concentra Group Holdings Parent, Inc. overvalued?
According to Wall Street analysts Concentra Group Holdings Parent, Inc.’s price is currently Undervalued.
Does Concentra Group Holdings Parent, Inc. pay dividends?
Concentra Group Holdings Parent, Inc. pays a Quarterly dividend of $0.063 which represents an annual dividend yield of 0.71%. See more information on Concentra Group Holdings Parent, Inc. dividends here
What is Concentra Group Holdings Parent, Inc.’s EPS estimate?
Concentra Group Holdings Parent, Inc.’s EPS estimate is 0.44.
How many shares outstanding does Concentra Group Holdings Parent, Inc. have?
Concentra Group Holdings Parent, Inc. has 127,517,740 shares outstanding.
What happened to Concentra Group Holdings Parent, Inc.’s price movement after its last earnings report?
Concentra Group Holdings Parent, Inc. reported an EPS of $0.52 in its last earnings report, beating expectations of $0.422. Following the earnings report the stock price went up 11.524%.
Which hedge fund is a major shareholder of Concentra Group Holdings Parent, Inc.?
Currently, no hedge funds are holding shares in CON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Concentra Group Holdings Parent, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$41.00 (17.88% Upside)
$41.00 (17.88% Upside)
Blogger Sentiment
Bullish
CON Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $8.1M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
71.83%
12-Months-Change
Fundamentals
Return on Equity
0.71%
Trailing 12-Months
Asset Growth
5.94%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational health solutions. The company delivers a comprehensive suite of occupational and consumer health services, encompassing treatment for workers' compensation injuries, urgent care, diagnostic clinical testing, preventative health measures, and employer-specific programs, along with wellness initiatives. These services are accessible through their network of occupational health centers and onsite clinics. Furthermore, Concentra offers specialized solutions like Concentra Telemed, a telemedicine platform for addressing work-related injuries and illnesses and supporting employer services; Concentra Pharmacy, providing pharmaceutical solutions; and Concentra Medical Compliance Administration, a third-party administrative service that assists employers in managing drug abuse testing programs for both regulated and non-regulated workforces. Established in 1979 and headquartered in Mechanicsburg, Pennsylvania, the company functions as a subsidiary of Select Medical Corporation.
CON Company Deck
CON Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call delivers a broadly positive message: robust top-line growth (10% revenue increase), notable margin expansion (EBITDA +22.5% and ~240 bps improvement), strong cash generation (operating cash flow and free cash flow roughly doubled YoY), successful acquisitions (Pivot/Nova ahead of underwriting), and updated, higher 2026 guidance. Manageable lowlights include comparability benefits from prior-year one-offs, expected moderation toward long-term visit growth, seasonality affecting margins, remaining debt/leveraging goals, and limited short-term contribution from new de novos. Overall, the strengths materially outweigh the risks and caveats discussed.View all CON earnings summariesCON Stock 12 Month Forecast
Average Price Target
$41.00
▲(17.88% Upside)
Technical Analysis
HCA Healthcare
―
US Physical Therapy
―
Universal Health
―
Starling Oncology Institute
―
DocGo
―
Ownership Overview
6.67% Insiders
34.16% Mutual Funds
15.31% Other Institutional Investors
17.87% Public Companies and
Individual Investors